Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The FROST Trial: 5-Fluorouracil in Pre-treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT07419464Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil in head and neck squamous cell carcinoma (HNSCC), sponsored by Washington University School of Medicine. Started Apr 2026; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07419464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07419464.